BioCryst Pharmaceuticals, Inc. Return on Tangible Assets

Return on Tangible Assets of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Return on Tangible Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Return on Tangible Assets for 2021 was -38.54% (a -51.71% decrease from previous year)
  • Annual Return on Tangible Assets for 2020 was -79.81% (a -39.21% decrease from previous year)
  • Annual Return on Tangible Assets for 2019 was -131.29% (a -29.98% decrease from previous year)
  • Twelve month Return on Tangible Assets ending September 30, 2022 was -44.36% (a -13.63% decrease compared to previous quarter)
  • Twelve month trailing Return on Tangible Assets increased by 13.54% year-over-year
Trailing Return on Tangible Assets for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
-44.36% -51.36% -44.14% -39.07%
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Return on Tangible Assets of BioCryst Pharmaceuticals, Inc.

Most recent Return on Tangible Assetsof BCRX including historical data for past 10 years.

Interactive Chart of Return on Tangible Assets of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Return on Tangible Assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -38.54%
2020 -79.81%
2019 -131.29%
2018 -187.5%
2017 -109.84%
2016 -244.55%
2015 -643.42%
2014 -140.09%
2013 -110.81%
2012 -154.24%

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology